ETODOLAC — all Canadian products
12 DINs
2 marketed/approved
0 in shortage
Every Health Canada Drug Identification Number whose active ingredient is ETODOLAC, with holder, form, strength and current status, compared weekly against the Drug Product Database.
| DIN | Product | Company | Form | Route | Strength | Status | Shortage |
|---|---|---|---|---|---|---|---|
| 02231965 | ETODOLAC | APOTEX INC | Capsule | Oral | ETODOLAC 200 MG | Approved | |
| 02231967 | ETODOLAC | APOTEX INC | Capsule | Oral | ETODOLAC 300 MG | Approved | |
| 02232318 | ETODOLAC | AA PHARMA INC | Capsule | Oral | ETODOLAC 300 MG | Dormant | |
| 02232317 | ETODOLAC | AA PHARMA INC | Capsule | Oral | ETODOLAC 200 MG | Dormant | |
| 02239319 | GEN-ETODOLAC 200MG | GENPHARM ULC | Capsule | Oral | ETODOLAC 200 MG | Cancelled Post Market | |
| 02239320 | GEN-ETODOLAC 300MG | GENPHARM ULC | Capsule | Oral | ETODOLAC 300 MG | Cancelled Post Market | |
| 02242205 | NOVO-ETODOLAC 200 MG | NOVOPHARM LIMITED | Capsule | Oral | ETODOLAC 200 MG | Cancelled Pre Market | |
| 02242206 | NOVO-ETODOLAC 300 MG | NOVOPHARM LIMITED | Capsule | Oral | ETODOLAC 300 MG | Cancelled Pre Market | |
| 02242915 | TARO-ETODOLAC | TARO PHARMACEUTICALS INC | Capsule | Oral | ETODOLAC 300 MG | Cancelled Post Market | |
| 02242914 | TARO-ETODOLAC 200 MG | TARO PHARMACEUTICALS INC | Capsule | Oral | ETODOLAC 200 MG | Cancelled Post Market | |
| 02142023 | ULTRADOL - CAP 200MG | PROCTER & GAMBLE PHARMACEUTICALS CANADA INC | Capsule | Oral | ETODOLAC 200 MG | Cancelled Post Market | |
| 02142031 | ULTRADOL - CAP 300MG | PROCTER & GAMBLE PHARMACEUTICALS CANADA INC | Capsule | Oral | ETODOLAC 300 MG | Cancelled Post Market |
Browse other molecules: